文献速递母胎医学产科

射频消融减胎术在复杂性多胎妊娠中的应用

[Clinical application for pregnacy outcomes of radiofrequency ablation in complex multiple pregnancies].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2019-01-01

回顾性分析156例复杂性单绒毛膜多胎妊娠行射频消融选择性减胎术,总存活率75.6%,<34周早产率19.5%。手术指征显著影响分娩孕周和新生儿出生体重,手术孕周和射频循环次数对妊娠结局无显著影响。

要点

  • RFA选择性减胎治疗复杂性单绒毛膜多胎妊娠总存活率75.6%(118/156)。
  • 手术指征不同,分娩孕周和新生儿出生体重差异有统计学意义(P均<0.05)。
  • 手术孕周<20周与≥20周、循环1次与≥2次组妊娠结局无显著差异(P均>0.05)。

核心结论

  • RFA行选择性减胎是治疗复杂性单绒毛膜多胎妊娠的安全、有效方法。
  • 手术指征可明显影响保留胎儿的结局。

研究设计与样本

  • 回顾性病例系列,纳入2011年7月22日至2018年9月12日山东大学附属省立医院156例行RFA选择性减胎的复杂性单绒毛膜多胎妊娠孕妇。

主要发现

  • 中位手术孕周20周(14周(+5)~29周(+1)),中位射频循环次数1次(1~3次),循环1次者占79.5%(124/156)。
  • 11例(7.1%,11/156)胎死宫内引产,27例(17.3%,27/156)流产,总存活率75.6%(118/156);<34周早产率19.5%(23/118)。
  • 新生儿共129例,中位出生孕周37周(+3)(28周(+2)~41周(+1)),平均出生体重(2 657±700)g。
  • 单绒毛膜双胎之一胎儿畸形组、多胎妊娠减胎组、TTTS组、sIUGR组与TRAPS组分娩孕周分别为38周(30周(+1)~41周(+1))、36周(+4)(29~39周)、36周(+4)(28周(+2)~39周(+5))、38周(31~39周(+6))、38周(+3)(30周(+4)~38周(+4)),新生儿出生体重分别为(2 820±671)、(2 435±416)、(2 497±843)、(2 998±718)、(2 517±1 087)g,组间差异均有统计学意义(P均<0.05)。
  • 手术孕周<20周组与≥20周组、循环1次组与≥2次组妊娠结局比较,差异均无统计学意义(P均>0.05)。

临床怎么用

  • RFA选择性减胎可用于复杂性单绒毛膜多胎妊娠,手术指征是影响保留胎儿结局的重要因素。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the safety and effectiveness of radiofrequency ablation (RFA) for selective fetal reduction in complex multiple pregnancies and analyze factors affecting perinatal outcomes. Methods: This was a retrospective case series of 156 patients undergoing selective fetal reduction by RFA in Provincial Hospital Affiliated to Shandong University from July 22th, 2011 to September 12th, 2018. They were divided into five groups according to surgical indications, including 46 cases in the monochorionic twins discordant for fetal anomalies group, 42 cases in the multiple pregnancies for reducing fetal numbers group, 40 cases in the twin to twin transfusion syndrome (TTTS) group, 24 cases in the selective intrauterine growth restriction (sIUGR) group and 4 cases in the twin reversed arterial perfusion sequence (TRAPS) group. According to the gestational age at surgery, patients were divided into two groups: the gestational age at surgery <20 weeks group (75 cases) and the gestational age at surgery≥20 weeks group (81 cases). According to the cycles of RFA required for surgery, patients were divided into two groups: one cycle group (124 cases) and ≥2 cycles group (32 cases). Basic information of patients, surgical process, postoperative complications and pregnancy outcomes were recorded. The growth and development of survival newborns were also followed up. Factors affecting perinatal outcomes were analyzed. Results: (1) The median gestational age at procedure of 156 patients was 20 weeks (14(+5)- 29(+1) weeks). The median cycles of RFA was 1 cycle (1-3 cycles), of which one cycle accounted for 79.5% (124/156). (2) Eleven (7.1%, 11/156) patients experienced intrauterine fetal death, 27 (17.3%, 27/156) patients miscarried, and the overall survival rate was 75.6% (118/156). Premature birth rate before 34 weeks was 19.5% (23/118). There were 129 neonates. The median gestational age at delivery was 37(+3) weeks (28(+2)- 41(+1) weeks) with a mean birth weight of (2 657±700) g. (3) Analysis of pregnancy outcomes based on surgical indications found that, the gestational age at delivery [38 weeks (30(+1)-41(+1) weeks), 36(+4) weeks (29- 39 weeks), 36(+4) weeks (28(+2)-39(+5) weeks), 38 weeks (31-39(+6) weeks), 38(+3) weeks (30(+4)-38(+4) weeks)] and neonatal birth weight [(2 820±671), (2 435±416), (2 497±843), (2 998±718), (2 517±1 087) g] were significantly different among fetal anomalies group, reducing fetal numbers group, TTTS group, sIUGR group and TRAPS group, respectively (all P<0.05). There were no significant differences in the pregnancy outcomes between gestational age at surgery <20 weeks group and gestational age at surgery ≥20 weeks group, or between one cycle group and ≥2 cycles group, respectively (all P>0.05). Conclusions: RFA is a safe and effective procedure in treating complex monochorionic multiple pregnancies. Surgical indications would affect the gestational age at delivery and neonatal outcomes. 目的: 探讨应用射频消融术(RFA)行选择性减胎术治疗复杂性多胎妊娠的安全性及有效性,并分析影响妊娠结局的因素。 方法: 回顾性分析2011年7月22日至2018年9月12日在山东大学附属省立医院行RFA选择性减胎治疗的156例复杂性单绒毛膜多胎妊娠孕妇的临床资料。按照手术指征分为5组,单绒毛膜双胎之一胎儿畸形组46例,多胎妊娠减胎组42例,双胎输血综合征(TTTS)组40例,选择性宫内生长受限(sIUGR)组24例,双胎动脉反向灌注序列征(TRAPS)组4例;根据手术孕周不同分为两组,手术孕周<20周组(75例)及手术孕周≥20周组(81例);根据手术所需射频循环的次数不同分为两组,循环1次组(124例)及循环≥2次组(32例)。记录孕妇的一般情况、RFA选择性减胎治疗的手术情况、术后并发症及妊娠结局,并随访保留胎儿出生后的生长发育情况,分析影响妊娠结局的相关因素。 结果: (1)156例孕妇的中位手术孕周为妊娠20周(14周(+5)~29周(+1)),手术所需中位射频循环次数为1次(1~3次),其中循环1次者占79.5%(124/156)。(2)术后11例(7.1%,11/156)孕妇的保留胎儿胎死宫内而引产,27例(17.3%,27/156)流产,保留胎儿的总存活率为75.6%(118/156)。妊娠<34周早产的发生率为19.5%(23/118);新生儿共129例,其中位出生孕周为37周(+)3(28周(+2)~41周(+1)),出生体重为(2 657±700)g。(3)对不同手术指征组孕妇的妊娠结局分析发现,单绒毛膜双胎之一胎儿畸形组、多胎妊娠减胎组、TTTS组、sIUGR组与TRAP组孕妇的分娩孕周[分别为妊娠38周(30周(+1)~41周(+1))、36周(+4)(29~39周)、36周(+4)(28周(+2)~39周(+5))、38周(31周~39周(+6))、38周(+)3(30周(+4)~38周(+4))]、新生儿出生体重[分别为(2 820±671)、(2 435±416)、(2 497±843)、(2 998±718)、(2 517±1 087)g],分别比较,差异均有统计学意义(P均<0.05)。而手术孕周<20周组与手术孕周≥20周组、循环1次组与循环≥2次组孕妇的妊娠结局分别比较,差异均无统计学意义(P均>0.05)。 结论: 采用RFA行选择性减胎是治疗复杂性单绒毛膜多胎妊娠的1种安全、有效的方法;手术指征可明显影响保留胎儿的结局。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Meng XL, Wang XT, Wang HM, et al. [Clinical application for pregnacy outcomes of radiofrequency ablation in complex multiple pregnancies]. Zhonghua Fu Chan Ke Za Zhi. 2019. PMID: 31752454. doi:10.3760/cma.j.issn.0529-567x.2019.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。